Annie De Groot is a Smith College graduate and medical doctor trained at the University of Chicago Pritzker School of Medicine. She trained in Internal Medicine and Infectious Disease at New England Medical Center and was a research fellow at the National Institutes of Health from 1986 to 1989. De Groot joined the faculty at Brown University in 1993, where she began to develop the cutting edge computational vaccine design tools for which she is well known.
De Groot is the co-founder and CEO/CSO of Epivax, Inc., a leading company in the field of immunoinformatics, working with a wide range of global clients and partners to improve the design of vaccines and biologics and improving human health everywhere. EpiVax will celebrate its 20th anniversary in 2018. De Groot also serves as director of the University of Rhode Island’s Institute for Immunology and Informatics and was awarded $13M in funding from the NIH to develop “iCubed” as a center of excellence in computational vaccinology. She is the author more than 190 peer-reviewed publications in the fields of computational vaccinology, biodefense, personalized vaccines, and immunology.
De Groot is the founder and volunteer medical director of Clinica Esperanza/Hope Clinic, which provides free medical care and preventive health services to adults living in Rhode Island who do not have health insurance. She is also the founder and scientific director of the GAIA Vaccine Foundation, a non-profit organization that works to improve the health of children and families in West Africa. She has won numerous awards, including the Smith Medal in 2013, was recognized as one of the 50 most influential people in vaccinology in 2014, and named Biotech CEO of the Year at the 2016 Vaccine Industry Excellence (ViE) Awards.